Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors.
about
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiaSafety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.Hepatocellular Toxicity Associated with Tyrosine Kinase Inhibitors: Mitochondrial Damage and Inhibition of Glycolysis.Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML).Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and Macrofilaricidal.Adverse events associated with tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.Imatinib mesylate in chronic myeloid leukemia: frontline treatment and long-term outcomes.The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice.Killing two birds with one stone: a case of GIST and supervening CML.Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines.Pharmacology and pharmacokinetics of imatinib in pediatric patients.
P2860
Q26749324-87D98D29-6B95-4C21-9E23-06DF2D136FECQ30891587-286674C0-1968-4AD5-9909-6FD6FA7F7B2AQ33794548-CB9748F1-5F73-4E3B-AAE4-205D44A98CBAQ34055591-B65F1001-47D1-4B09-A409-685C9D6BD7C2Q35965183-BC59AAB8-46B9-445A-8F25-99ADAF42D85DQ38707841-09B10471-2A76-4C7D-AAF6-E06921E52883Q38725366-45B6951C-E1DE-4430-A503-86C4104DB9D5Q42370730-43BBEB8E-43E7-4C1C-B31D-8DE44B443F08Q43211315-667744B0-68A6-4BEA-AB94-349B4240809CQ46274363-B19F8F82-A6F0-4FC8-A1A1-9B9D064FE306Q50094239-9F3EC7A9-F86B-43C9-AAB8-D3A57E57A597
P2860
Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Occurrence and current managem ...... th tyrosine kinase inhibitors.
@en
type
label
Occurrence and current managem ...... th tyrosine kinase inhibitors.
@en
prefLabel
Occurrence and current managem ...... th tyrosine kinase inhibitors.
@en
P1433
P1476
Occurrence and current managem ...... th tyrosine kinase inhibitors.
@en
P304
P356
10.1016/J.LEUKRES.2013.01.021
P577
2013-03-07T00:00:00Z